EOFY Special: Save on our reports Save $150 Small Cap + Blue Chip Reports Access Now
x

Which Shares to Buy Now?

Richard Hemming


The stock market is highly volatile creating buying opportunities for new investors. Under the Radar Report recommends you buy shares right now that we believe can generate strong returns because they are good value. Which are which are the best shares to buy now?

Choosing the right shares to buy

The stock market turmoil can make it hard for you to choose which shares to buy now. It is important to have strong research when you invest in shares and buying the right stock for your investment goals is critical. However, it can take a long time to research every share you buy.

Which shares to buy, hold and sell

At Under the Radar Report we tell you exactly which shares to buy and when. Our team of expert analysts help you confidently choose which shares to Buy, Hold and Sell now. We provide 10 of the best shares to buy now each week which provides growth for our subscribers. We are currently recommending investors buy in small parcels and not chase stock prices, which has proven to be the right advice.

Here are three stocks to buy now 

1. Hansen Technologies (HSN)

This is a great stock to buy now and has been operating for almost 50 years. Hansen Technologies provides billing software for infrastructure companies and telcos. Its customers are Blue Chip and they stick. On top of that, the company only pays out of its earnings in dividends.

2. Freedom Foods (FNP)

Freedom Foods is another great stock to buy now as consumers are increasingly looking to purchase dairy and plant-based products including milk, nutritional powders, cereals, muesli bars and nuts. The group said it is experiencing  “strong demand for key products” and will continue to supply domestic and export markets. The group does have debt of almost $200 million but based on similar companies we think Freedom has enough room to move.

3. Medical Developments (MVP)

This stock to buy now is on the riskier side. The specialist pharmaceutical company Medical Developments (MVP) is on the riskier side compared to the other two, but there is still a chance of achieving similar market penetration in non-opioid pain relief around the world that it has achieved in Australia, with its famed Green Whistle aka Penthrox.

For a full list of stocks to buy now that we are recommending, sign up for our 14 day free trial. You can't afford to miss out. 

About the Author

Richard Hemming

Richard Hemming (r.hemming@undertheradarreport.com.au) is an independent analyst who edits www.undertheradarreport.com.au, which provides investment opportunities in Small Caps that you won’t get anywhere else.

Under the Radar Report is licensed to give general financial advice only (AFSL: 409518). The author does not own shares in any of the stocks mentioned.

Did you miss?

As Seen In